Note 15 - Subsequent Event (Details Textual) - Subsequent Event [Member] - USD ($) $ in Millions |
1 Months Ended | |||
---|---|---|---|---|
Aug. 01, 2016 |
Jul. 01, 2016 |
Aug. 26, 2016 |
Jul. 28, 2016 |
|
Space [Member] | ||||
Payments to Acquire Businesses, Gross | $ 11.0 | |||
Advanced Cell Diagnostics (ACD) [Member] | Upon the Achievement of Certain Milestones [Member] | ||||
Business Combination, Contingent Consideration, Liability | $ 75.0 | |||
Advanced Cell Diagnostics (ACD) [Member] | ||||
Payments to Acquire Businesses, Gross | $ 250.0 | |||
Revolving Credit Facility [Member] | ||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 400.0 | |||
Proceeds from Lines of Credit | $ 250.0 |
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|